Last reviewed · How we verify
NCT04178239
Chronic Fatigue in Sarcoidosis
trial testing fMRI, questionnaires, pneumologic diagnostics in Sarcoidosis in 31 participants. Completed in 2 February 2018.
2 February 2018
Quick facts
| Lead sponsor | RWTH Aachen University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 31 |
| Start date | 10 March 2017 |
| Primary completion | 2 February 2018 |
| Estimated completion | 2 February 2018 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- fMRI, questionnaires, pneumologic diagnostics
Conditions studied
- Sarcoidosis — all drugs for Sarcoidosis →
Sponsor
RWTH Aachen University
Who can join
18 and older, any sex, with Sarcoidosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Chronic fatigue (CF) is a prominent symptom in many sarcoidosis patients, affecting quality of life (QoL) and interfering with treatment. This study investigates neuropsychobiological mechanisms and markers of CF in sarcoidosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Neuropsychobiological Fingerprints of Chronic Fatigue in Sarcoidosis.
Kettenbach S, Radke S, Müller T, Habel U, et al · · 2021 · cited 5× · PMID 34381339 · DOI 10.3389/fnbeh.2021.633005
Verify or expand the search:
- PubMed search for NCT04178239
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcoidosis
Currently open trials in the same condition.
- NCT07498842 — Corticosteroid Tapering in Sarcoidosis · NA · recruiting
- NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
- NCT07384897 — Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease · NA · recruiting
- NCT06636487 — Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD · NA · active not recruiting
- NCT06576505 — Immunological Mechanisms in Sarcoidosis · recruiting
Other RWTH Aachen University trials
Trials by the same sponsor.
- NCT06390384 — Prevention Programme for Improvement of Well-being and Level of Participation in Adolescents With Enhanced Psychiatric B · NA · not yet recruiting
- NCT07322796 — Smoking Cessation Before Bronchoscopy or CT-guided Puncture · recruiting
- NCT04996914 — Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma · NA · not yet recruiting
- NCT07053956 — Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma · NA · completed
- NCT07140536 — The Impact of Treadmills and Cooler Environments for Office Workplaces on Ergonomics, Heating Energy Requirements, Perfo · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04178239 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RWTH Aachen University
- Last refreshed: 27 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04178239.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing